Pharmacokinetics, Efficacy, Safety, and Immunogenicity of SB5 Versus Humira in Subjects With Moderate to Severe Chronic Plaque Psoriasis
Clinical trial NCT05510063 · COMPLETED
Trial details
- NCT number
- NCT05510063
- Sponsor
- Samsung Bioepis Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2022-08-04
- Primary completion
- 2023-04-04
- Enrollment
- 371
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.